Views & Analysis Unlocking the gut microbiome’s secrets Every decade or so science finds a new mountain to climb, and the gut microbiome is our latest Mount Kilimanjaro.
News After setback, Rhythm gets good news on Imcivree from FDA Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
